Company / Book Value per Share
Monopar Therapeutics Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$22.585
FY2025
5-year range
$0.779 / $22.585
FY2021-FY2025
Trend
+1104.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share changed +1105% YoY in FY2025, a notable deviation from the 4-year average annual change of +308%.
Based on SEC 10-K filings.
$22.585 in FY2025.
Improved from $0.779 to $22.585 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, book value per share increased 1104.9% year-over-year.
- Lowest book value per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 19.82 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.585 | +1104.9% |
| FY2024 | $1.875 | +140.5% |
| FY2023 | $0.779 | -42.7% |
| FY2019 | $1.359 | +31.3% |
| FY2018 | $1.035 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026